GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verona Pharma PLC (GREY:VNAPF) » Definitions » Net Interest Income (for Banks)

Verona Pharma (Verona Pharma) Net Interest Income (for Banks)


View and export this data going back to 2008. Start your Free Trial

What is Verona Pharma Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Verona Pharma (Verona Pharma) Business Description

Industry
Traded in Other Exchanges
Address
3 More London Riverside, London, GBR, SE1 2RE
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma. The company is engaged in pharmaceutical development.